Alendronate tracheobronchitis

Ann Am Thorac Soc. 2013 Feb;10(1):64-6. doi: 10.1513/AnnalsATS.201212-124OT.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alendronate / administration & dosage
  • Alendronate / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects
  • Bronchitis* / chemically induced
  • Bronchitis* / diagnosis
  • Bronchitis* / physiopathology
  • Bronchitis* / therapy
  • Bronchoscopy / methods*
  • Debridement
  • Female
  • Humans
  • Middle Aged
  • Osteoporosis / drug therapy
  • Prednisone / therapeutic use
  • Respiratory System* / pathology
  • Respiratory System* / physiopathology
  • Respiratory System* / surgery
  • Tracheitis* / chemically induced
  • Tracheitis* / diagnosis
  • Tracheitis* / physiopathology
  • Tracheitis* / therapy
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Bone Density Conservation Agents
  • Prednisone
  • Alendronate